Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05366218
Title Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemia (Anti-CD19-ALL)
Acronym Anti-CD19-ALL
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University Hospital Tuebingen
Indications
Therapies
Age Groups: adult | child
Covered Countries DEU

Facility Status City State Zip Country Details
Universitätsklinikum Freiburg RECRUITING Freiburg Baden-Württemberg 79106 Germany Details
University childrens Hospital RECRUITING Tübingen Baden-Württemberg 72076 Germany Details
Klinik für Kinder- und Jugendmedizin RECRUITING Ulm Baden-Württemberg 89070 Germany Details
Klinikum Dr. von Haunersches Kinderspital NOT_YET_RECRUITING München Bayern 80337 Germany Details
Universitätsklinikum Düsseldorf RECRUITING Düsseldorf Nordrhein-Westfalen 40225 Germany Details
Universitätsmedizin Berlin, Campus Virchow Klinikum RECRUITING Berlin 13353 Germany Details
Universitätsklinikum NOT_YET_RECRUITING Essen 45147 Germany Details
Universitätsklinikum, Klinik für Kinder- und Jugendmedizin NOT_YET_RECRUITING Frankfurt 60590 Germany Details
Zentrum für Geburtshilfe, Kinder- und Jugendmedizin RECRUITING Hamburg 20246 Germany Details
Universitätsklinikum Schleswig-Holstein, Campus Kiel RECRUITING Kiel 24105 Germany Details
Universitäts-Kinderklinik RECRUITING Würzburg 97080 Germany Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field